Dear Colleagues,

The USAID-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program is excited to announce the launch of the Using New TB Medicines and Regimens eCourse—a free, self-paced course for health professionals on new TB medicines, such as bedaquiline and delamanid, and new regimens, such as the nine-month regimen. The course also covers responsible use of these medicines and regimens for the treatment of multi-drug-resistant TB (MDR-TB).

This course is intended for use by physicians, nurses, pharmacists, and all health care workers who are currently engaged in the management of MDR-TB patients. Workers in national TB control programs, ministries of health, and nongovernmental organizations who are looking to introduce new TB medicines and regimens in their countries will also greatly benefit from this course.

The eCourse is available on Leadernet.org. The information in this course has been developed on the basis of publicly available resources from the World Health Organization and elsewhere. It has been taught via in-person workshops to hundreds of health care workers in five countries. Now this information is available to you at no cost.

The course includes eight modules with interactive case studies. You can choose to review all the modules in this course or simply pick the ones that are most relevant to your practice setting. Whether you are new to the topics and want to view the entire course in sequential order, or if you a need a refresher or want to view a specific topic or resource, you can do so. You do not have to complete all the modules at once; you can go at your own pace and learn in your free time as desired. A certificate will be provided for those who complete the full course.

For more information or to register for this free course, please visit https://leadernet.org/groups/courses/using-new-tb-medicines-and-regimens/.

Best regards,

SIAPS Program